

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular visceral epithelial cell development (GO:0072015) | 8.91611771 |
| 2 | glomerular epithelial cell development (GO:0072310) | 8.16479153 |
| 3 | glomerular basement membrane development (GO:0032836) | 7.52142258 |
| 4 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.29429500 |
| 5 | plasma membrane repair (GO:0001778) | 3.94234495 |
| 6 | endothelial cell chemotaxis (GO:0035767) | 3.92281209 |
| 7 | positive regulation of histone deacetylation (GO:0031065) | 3.79648948 |
| 8 | protein localization to endosome (GO:0036010) | 3.70171189 |
| 9 | venous blood vessel morphogenesis (GO:0048845) | 3.67809431 |
| 10 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.54876135 |
| 11 | negative regulation of cell size (GO:0045792) | 3.50564535 |
| 12 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.49688775 |
| 13 | cardiac myofibril assembly (GO:0055003) | 3.49287236 |
| 14 | glomerulus development (GO:0032835) | 3.45357808 |
| 15 | stress fiber assembly (GO:0043149) | 3.39854238 |
| 16 | definitive hemopoiesis (GO:0060216) | 3.36963733 |
| 17 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.36098416 |
| 18 | regulation of early endosome to late endosome transport (GO:2000641) | 3.27777707 |
| 19 | sarcomere organization (GO:0045214) | 3.21603168 |
| 20 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.19186630 |
| 21 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.17165941 |
| 22 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.14210534 |
| 23 | positive regulation of receptor recycling (GO:0001921) | 3.10648091 |
| 24 | blood vessel maturation (GO:0001955) | 3.09520667 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09259221 |
| 26 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.08564110 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 3.07488089 |
| 28 | adherens junction assembly (GO:0034333) | 3.04901076 |
| 29 | epithelial cell-cell adhesion (GO:0090136) | 3.03666155 |
| 30 | positive regulation of protein deacetylation (GO:0090312) | 3.03558672 |
| 31 | positive regulation of lamellipodium assembly (GO:0010592) | 3.03100574 |
| 32 | negative regulation of vascular permeability (GO:0043116) | 3.00438678 |
| 33 | cell-substrate adherens junction assembly (GO:0007045) | 2.99893596 |
| 34 | focal adhesion assembly (GO:0048041) | 2.99893596 |
| 35 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.99357301 |
| 36 | coronary vasculature morphogenesis (GO:0060977) | 2.98336034 |
| 37 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.93304842 |
| 38 | axon extension involved in axon guidance (GO:0048846) | 2.93304842 |
| 39 | activation of protein kinase A activity (GO:0034199) | 2.93300807 |
| 40 | mannose metabolic process (GO:0006013) | 2.88279880 |
| 41 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.87613617 |
| 42 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.87097508 |
| 43 | cell communication by electrical coupling (GO:0010644) | 2.86615510 |
| 44 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.85988323 |
| 45 | cell-cell junction maintenance (GO:0045217) | 2.83835346 |
| 46 | lymphangiogenesis (GO:0001946) | 2.81748072 |
| 47 | sprouting angiogenesis (GO:0002040) | 2.81126796 |
| 48 | semaphorin-plexin signaling pathway (GO:0071526) | 2.80875579 |
| 49 | heart trabecula formation (GO:0060347) | 2.79493315 |
| 50 | regulation of p38MAPK cascade (GO:1900744) | 2.77880085 |
| 51 | response to peptidoglycan (GO:0032494) | 2.76025939 |
| 52 | sodium ion export (GO:0071436) | 2.75974412 |
| 53 | renal filtration (GO:0097205) | 2.75082147 |
| 54 | embryonic hemopoiesis (GO:0035162) | 2.74151558 |
| 55 | megakaryocyte development (GO:0035855) | 2.72863449 |
| 56 | regulation of ARF protein signal transduction (GO:0032012) | 2.72687256 |
| 57 | protein retention in ER lumen (GO:0006621) | 2.72385098 |
| 58 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72184700 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.72184700 |
| 60 | synaptic vesicle maturation (GO:0016188) | 2.71357150 |
| 61 | cortical actin cytoskeleton organization (GO:0030866) | 2.69868080 |
| 62 | positive regulation of lamellipodium organization (GO:1902745) | 2.69827172 |
| 63 | patterning of blood vessels (GO:0001569) | 2.68266478 |
| 64 | response to laminar fluid shear stress (GO:0034616) | 2.68019387 |
| 65 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.67751906 |
| 66 | cardiac muscle contraction (GO:0060048) | 2.65475231 |
| 67 | lymph vessel development (GO:0001945) | 2.63173735 |
| 68 | regulation of axon guidance (GO:1902667) | 2.58660655 |
| 69 | skin morphogenesis (GO:0043589) | 2.58420303 |
| 70 | barbed-end actin filament capping (GO:0051016) | 2.57774120 |
| 71 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.56263171 |
| 72 | positive regulation of axon extension (GO:0045773) | 2.55925731 |
| 73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55721338 |
| 74 | substrate-dependent cell migration (GO:0006929) | 2.53258886 |
| 75 | response to muramyl dipeptide (GO:0032495) | 2.53125585 |
| 76 | germ cell migration (GO:0008354) | 2.51098102 |
| 77 | cardiac muscle cell proliferation (GO:0060038) | 2.50736316 |
| 78 | positive regulation of vascular permeability (GO:0043117) | 2.50564306 |
| 79 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49864750 |
| 80 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.49698492 |
| 81 | positive regulation of protein dephosphorylation (GO:0035307) | 2.48717556 |
| 82 | protein targeting to plasma membrane (GO:0072661) | 2.48400096 |
| 83 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.46579337 |
| 84 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.46579337 |
| 85 | modulation by symbiont of host immune response (GO:0052553) | 2.46579337 |
| 86 | positive regulation by symbiont of host defense response (GO:0052509) | 2.46579337 |
| 87 | modulation by symbiont of host defense response (GO:0052031) | 2.46579337 |
| 88 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.46579337 |
| 89 | peptidyl-lysine dimethylation (GO:0018027) | 2.45800134 |
| 90 | myofibril assembly (GO:0030239) | 2.45371762 |
| 91 | regulation of erythrocyte differentiation (GO:0045646) | 2.45300734 |
| 92 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.44922655 |
| 93 | macrophage activation involved in immune response (GO:0002281) | 2.43546487 |
| 94 | positive regulation of fibroblast migration (GO:0010763) | 2.43172971 |
| 95 | positive regulation of Rap GTPase activity (GO:0032854) | 2.42702438 |
| 96 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.42018282 |
| 97 | locomotory exploration behavior (GO:0035641) | 2.41470038 |
| 98 | endocytic recycling (GO:0032456) | 2.41172377 |
| 99 | atrioventricular valve morphogenesis (GO:0003181) | 2.40905302 |
| 100 | cell-substrate junction assembly (GO:0007044) | 2.40350679 |
| 101 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.39788058 |
| 102 | blood vessel endothelial cell migration (GO:0043534) | 2.39342085 |
| 103 | ribosomal small subunit assembly (GO:0000028) | 2.39288680 |
| 104 | cortical cytoskeleton organization (GO:0030865) | 2.37936059 |
| 105 | regulation of ARF GTPase activity (GO:0032312) | 2.37781247 |
| 106 | regulation of vascular permeability (GO:0043114) | 2.36731662 |
| 107 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.36094044 |
| 108 | cardiac muscle cell development (GO:0055013) | 2.34453364 |
| 109 | protein heterotrimerization (GO:0070208) | 2.33497328 |
| 110 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.33477707 |
| 111 | NADH metabolic process (GO:0006734) | 2.32699732 |
| 112 | regulation of leukocyte degranulation (GO:0043300) | 2.31349999 |
| 113 | cell volume homeostasis (GO:0006884) | 2.30488480 |
| 114 | positive regulation of extracellular matrix organization (GO:1903055) | 2.30309624 |
| 115 | basement membrane organization (GO:0071711) | 2.30016670 |
| 116 | virion attachment to host cell (GO:0019062) | 2.29296128 |
| 117 | adhesion of symbiont to host cell (GO:0044650) | 2.29296128 |
| 118 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.29155459 |
| 119 | oxygen transport (GO:0015671) | 2.29121864 |
| 120 | germinal center formation (GO:0002467) | 2.28347343 |
| 121 | positive regulation of synapse maturation (GO:0090129) | 2.28300968 |
| 122 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.27922784 |
| 123 | adenosine receptor signaling pathway (GO:0001973) | 2.27620353 |
| 124 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.26236748 |
| 125 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.26175294 |
| 126 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.25484211 |
| 127 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.25054404 |
| 128 | response to fluid shear stress (GO:0034405) | 2.24630137 |
| 129 | actomyosin structure organization (GO:0031032) | 2.24377285 |
| 130 | heparin biosynthetic process (GO:0030210) | 2.23506248 |
| 131 | heparin metabolic process (GO:0030202) | 2.23506248 |
| 132 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.23166913 |
| 133 | embryonic heart tube development (GO:0035050) | 2.22981661 |
| 134 | hyaluronan catabolic process (GO:0030214) | 2.22362700 |
| 135 | cAMP biosynthetic process (GO:0006171) | 2.22102564 |
| 136 | regulation of macrophage cytokine production (GO:0010935) | 2.21642097 |
| 137 | activation of Rac GTPase activity (GO:0032863) | 2.20973096 |
| 138 | lamellipodium assembly (GO:0030032) | 2.20951646 |
| 139 | endothelium development (GO:0003158) | 2.20821162 |
| 140 | adhesion of symbiont to host (GO:0044406) | 2.20798112 |
| 141 | modulation by symbiont of host cellular process (GO:0044068) | 2.19845884 |
| 142 | actin filament bundle assembly (GO:0051017) | 2.19613664 |
| 143 | actin filament bundle organization (GO:0061572) | 2.19613664 |
| 144 | negative regulation of heart growth (GO:0061117) | 2.19090942 |
| 145 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.19090942 |
| 146 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.18995918 |
| 147 | regulation of extracellular matrix disassembly (GO:0010715) | 2.18373020 |
| 148 | cell migration involved in heart development (GO:0060973) | 2.18118073 |
| 149 | cell adhesion mediated by integrin (GO:0033627) | 2.17772763 |
| 150 | signal complex assembly (GO:0007172) | 2.17629807 |
| 151 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.16281527 |
| 152 | activation of MAPKKK activity (GO:0000185) | 2.14682172 |
| 153 | NIK/NF-kappaB signaling (GO:0038061) | 2.13234453 |
| 154 | regulation of mast cell degranulation (GO:0043304) | 2.13135500 |
| 155 | synaptic vesicle exocytosis (GO:0016079) | 2.12998143 |
| 156 | cell junction maintenance (GO:0034331) | 2.11659603 |
| 157 | modulation by virus of host morphology or physiology (GO:0019048) | 2.10167879 |
| 158 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.09937419 |
| 159 | detection of molecule of bacterial origin (GO:0032490) | 2.06987725 |
| 160 | fibril organization (GO:0097435) | 2.06422662 |
| 161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.05792458 |
| 162 | extracellular fibril organization (GO:0043206) | 2.04700688 |
| 163 | negative regulation of fatty acid transport (GO:2000192) | 2.04630305 |
| 164 | regulation of regulated secretory pathway (GO:1903305) | 2.04386653 |
| 165 | glutamate secretion (GO:0014047) | 2.04068260 |
| 166 | activation of JUN kinase activity (GO:0007257) | 2.03877171 |
| 167 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.01517613 |
| 168 | actin filament depolymerization (GO:0030042) | 2.01245167 |
| 169 | apoptotic cell clearance (GO:0043277) | 2.00713696 |
| 170 | cellular response to catecholamine stimulus (GO:0071870) | 2.00291750 |
| 171 | cellular response to monoamine stimulus (GO:0071868) | 2.00291750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.37218285 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.08137128 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.05125900 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.00471014 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.75606749 |
| 6 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.72845846 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.66793640 |
| 8 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.60499105 |
| 9 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.49866866 |
| 10 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.49647836 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.40142144 |
| 12 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.37775965 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32329621 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.31576374 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.31145272 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.20602455 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16064989 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14711761 |
| 19 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.09439570 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05092181 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02507293 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.98541045 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.96547450 |
| 24 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.96235208 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.94113589 |
| 26 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85369918 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81859331 |
| 28 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.80414575 |
| 29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.76918682 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76115029 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.74647468 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74217817 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73973834 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73500716 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69962837 |
| 36 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.69611995 |
| 37 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.68814436 |
| 38 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.61005862 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59538076 |
| 40 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.59315483 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58904024 |
| 42 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.58307936 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57698370 |
| 44 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55907320 |
| 45 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.55758257 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55523142 |
| 47 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.51892940 |
| 48 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51749645 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51698097 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.45877541 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42825353 |
| 52 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41645086 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41533220 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37800797 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37655315 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37552763 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.35304819 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34810588 |
| 59 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.34239138 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34045270 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33491941 |
| 62 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.33013971 |
| 63 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.32999038 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32730893 |
| 65 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31067647 |
| 66 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.30151353 |
| 67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29809557 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29586202 |
| 69 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28417920 |
| 70 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27627588 |
| 71 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27627588 |
| 72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26991650 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25583751 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24984685 |
| 75 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.24648804 |
| 76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23922648 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23573262 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23204636 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22979642 |
| 80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.22021561 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21164635 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21092310 |
| 83 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20300966 |
| 84 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.20046222 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 1.18704474 |
| 86 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18598135 |
| 87 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.18387456 |
| 88 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17196473 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15863949 |
| 90 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15721007 |
| 91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15653351 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15415687 |
| 93 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15299448 |
| 94 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.14393327 |
| 95 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14181763 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13138411 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.13028238 |
| 98 | MAF_26560356_Chip-Seq_TH2_Human | 1.11785588 |
| 99 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.11253103 |
| 100 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.11116319 |
| 101 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10254865 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09497298 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09455921 |
| 104 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08437037 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08274030 |
| 106 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08226703 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08102191 |
| 108 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06727240 |
| 109 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.06712367 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06662307 |
| 111 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06318415 |
| 112 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06126549 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06067011 |
| 114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05640184 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04070001 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03453985 |
| 117 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03312823 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03205434 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01162033 |
| 120 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01132567 |
| 121 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00896109 |
| 122 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00791584 |
| 123 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00548568 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00496489 |
| 125 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00488073 |
| 126 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00348016 |
| 127 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.98920644 |
| 128 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98702835 |
| 129 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98363958 |
| 130 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98250942 |
| 131 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97739990 |
| 132 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96879335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 4.30634059 |
| 2 | MP0010368_abnormal_lymphatic_system | 3.67443378 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 2.90578085 |
| 4 | MP0000751_myopathy | 2.86092778 |
| 5 | MP0005623_abnormal_meninges_morphology | 2.83813315 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.83474555 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 2.68142110 |
| 8 | MP0004036_abnormal_muscle_relaxation | 2.64209650 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.61266732 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.45719309 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.38013006 |
| 12 | MP0004808_abnormal_hematopoietic_stem | 2.32042832 |
| 13 | MP0006054_spinal_hemorrhage | 2.29495632 |
| 14 | MP0008961_abnormal_basal_metabolism | 2.25933118 |
| 15 | MP0003436_decreased_susceptibility_to | 2.18772425 |
| 16 | MP0009840_abnormal_foam_cell | 2.08626629 |
| 17 | MP0004272_abnormal_basement_membrane | 2.05176617 |
| 18 | MP0003279_aneurysm | 2.04287513 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.02425005 |
| 20 | MP0001545_abnormal_hematopoietic_system | 2.02425005 |
| 21 | MP0005409_darkened_coat_color | 2.02409342 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.01987697 |
| 23 | MP0005451_abnormal_body_composition | 2.01916250 |
| 24 | MP0009278_abnormal_bone_marrow | 2.01217701 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.97471281 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.96279066 |
| 27 | MP0004858_abnormal_nervous_system | 1.94345846 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.91400700 |
| 29 | MP0000749_muscle_degeneration | 1.90198689 |
| 30 | MP0005330_cardiomyopathy | 1.89876412 |
| 31 | MP0008775_abnormal_heart_ventricle | 1.87910355 |
| 32 | MP0008260_abnormal_autophagy | 1.86299567 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.83169388 |
| 34 | MP0001849_ear_inflammation | 1.81781523 |
| 35 | MP0003828_pulmonary_edema | 1.81719652 |
| 36 | MP0010630_abnormal_cardiac_muscle | 1.79568313 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.74852395 |
| 38 | MP0003646_muscle_fatigue | 1.70213368 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.65435630 |
| 40 | MP0005385_cardiovascular_system_phenoty | 1.63537673 |
| 41 | MP0001544_abnormal_cardiovascular_syste | 1.63537673 |
| 42 | MP0003329_amyloid_beta_deposits | 1.63463248 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.56506571 |
| 44 | MP0006138_congestive_heart_failure | 1.56383353 |
| 45 | MP0000747_muscle_weakness | 1.53420343 |
| 46 | MP0004484_altered_response_of | 1.50779296 |
| 47 | MP0002972_abnormal_cardiac_muscle | 1.49233880 |
| 48 | MP0004233_abnormal_muscle_weight | 1.48014609 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.47414322 |
| 50 | MP0002269_muscular_atrophy | 1.46204979 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.42920551 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.42675184 |
| 53 | MP0002106_abnormal_muscle_physiology | 1.39293895 |
| 54 | MP0005275_abnormal_skin_tensile | 1.39278851 |
| 55 | MP0003724_increased_susceptibility_to | 1.38801414 |
| 56 | MP0003075_altered_response_to | 1.35758167 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.35486314 |
| 58 | MP0003879_abnormal_hair_cell | 1.33286000 |
| 59 | MP0002128_abnormal_blood_circulation | 1.30906014 |
| 60 | MP0005620_abnormal_muscle_contractility | 1.29960210 |
| 61 | MP0003303_peritoneal_inflammation | 1.25858303 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.22994958 |
| 63 | MP0004130_abnormal_muscle_cell | 1.22838552 |
| 64 | MP0004085_abnormal_heartbeat | 1.21504671 |
| 65 | MP0003091_abnormal_cell_migration | 1.21236104 |
| 66 | MP0003122_maternal_imprinting | 1.21070876 |
| 67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.20106138 |
| 68 | MP0002419_abnormal_innate_immunity | 1.19384682 |
| 69 | MP0001958_emphysema | 1.17685885 |
| 70 | MP0000759_abnormal_skeletal_muscle | 1.17556570 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.17325814 |
| 72 | MP0005595_abnormal_vascular_smooth | 1.17135418 |
| 73 | MP0001542_abnormal_bone_strength | 1.16987200 |
| 74 | MP0000604_amyloidosis | 1.16613787 |
| 75 | MP0004947_skin_inflammation | 1.16347726 |
| 76 | MP0000266_abnormal_heart_morphology | 1.16173915 |
| 77 | MP0003635_abnormal_synaptic_transmissio | 1.15231290 |
| 78 | MP0005369_muscle_phenotype | 1.14096938 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 1.13324713 |
| 80 | MP0003690_abnormal_glial_cell | 1.12915815 |
| 81 | MP0005423_abnormal_somatic_nervous | 1.12348235 |
| 82 | MP0000343_altered_response_to | 1.12149390 |
| 83 | MP0002295_abnormal_pulmonary_circulatio | 1.11304089 |
| 84 | MP0002925_abnormal_cardiovascular_devel | 1.11021963 |
| 85 | MP0002933_joint_inflammation | 1.10621247 |
| 86 | MP0004510_myositis | 1.08200354 |
| 87 | MP0002909_abnormal_adrenal_gland | 1.07072460 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 1.06225620 |
| 89 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05789385 |
| 90 | MP0002089_abnormal_postnatal_growth/wei | 1.03525688 |
| 91 | MP0001790_abnormal_immune_system | 1.03338182 |
| 92 | MP0005387_immune_system_phenotype | 1.03338182 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 1.02680574 |
| 94 | MP0005390_skeleton_phenotype | 1.01623299 |
| 95 | MP0003137_abnormal_impulse_conducting | 1.01334391 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.98966123 |
| 97 | MP0000920_abnormal_myelination | 0.98687799 |
| 98 | MP0001915_intracranial_hemorrhage | 0.96516564 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.96246738 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.95844502 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.95544133 |
| 102 | MP0008874_decreased_physiological_sensi | 0.95528798 |
| 103 | MP0000733_abnormal_muscle_development | 0.94997858 |
| 104 | MP0005025_abnormal_response_to | 0.94996726 |
| 105 | MP0009384_cardiac_valve_regurgitation | 0.93750521 |
| 106 | MP0008770_decreased_survivor_rate | 0.93592919 |
| 107 | MP0001614_abnormal_blood_vessel | 0.93146392 |
| 108 | MP0005670_abnormal_white_adipose | 0.92602814 |
| 109 | MP0000685_abnormal_immune_system | 0.91981034 |
| 110 | MP0003634_abnormal_glial_cell | 0.91849233 |
| 111 | MP0000249_abnormal_blood_vessel | 0.91405693 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.91227513 |
| 113 | MP0006082_CNS_inflammation | 0.91181493 |
| 114 | MP0003984_embryonic_growth_retardation | 0.89445542 |
| 115 | MP0001784_abnormal_fluid_regulation | 0.87678789 |
| 116 | MP0003045_fibrosis | 0.87068913 |
| 117 | MP0005166_decreased_susceptibility_to | 0.86356807 |
| 118 | MP0005164_abnormal_response_to | 0.85240452 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.84603311 |
| 120 | MP0008438_abnormal_cutaneous_collagen | 0.84189505 |
| 121 | MP0005503_abnormal_tendon_morphology | 0.83695645 |
| 122 | MP0002088_abnormal_embryonic_growth/wei | 0.82604711 |
| 123 | MP0005000_abnormal_immune_tolerance | 0.82147986 |
| 124 | MP0002234_abnormal_pharynx_morphology | 0.81649440 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.80604206 |
| 126 | MP0001851_eye_inflammation | 0.80515290 |
| 127 | MP0008004_abnormal_stomach_pH | 0.79162128 |
| 128 | MP0005508_abnormal_skeleton_morphology | 0.78528749 |
| 129 | MP0003943_abnormal_hepatobiliary_system | 0.78327265 |
| 130 | MP0008569_lethality_at_weaning | 0.77621571 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.77014906 |
| 132 | MP0002135_abnormal_kidney_morphology | 0.76857530 |
| 133 | MP0002086_abnormal_extraembryonic_tissu | 0.76216344 |
| 134 | MP0003448_altered_tumor_morphology | 0.75106875 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.73112608 |
| 136 | MP0000678_abnormal_parathyroid_gland | 0.72727838 |
| 137 | MP0002060_abnormal_skin_morphology | 0.72530264 |
| 138 | MP0005165_increased_susceptibility_to | 0.71111087 |
| 139 | MP0002133_abnormal_respiratory_system | 0.69624105 |
| 140 | MP0005388_respiratory_system_phenotype | 0.69624105 |
| 141 | MP0002127_abnormal_cardiovascular_syste | 0.69302231 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.69095591 |
| 143 | MP0002970_abnormal_white_adipose | 0.68717659 |
| 144 | MP0004811_abnormal_neuron_physiology | 0.68643964 |
| 145 | MP0005023_abnormal_wound_healing | 0.67638826 |
| 146 | MP0003795_abnormal_bone_structure | 0.67284567 |
| 147 | MP0002063_abnormal_learning/memory/cond | 0.67020431 |
| 148 | MP0002249_abnormal_larynx_morphology | 0.66911555 |
| 149 | MP0005621_abnormal_cell_physiology | 0.66630713 |
| 150 | MP0002080_prenatal_lethality | 0.65396279 |
| 151 | MP0004145_abnormal_muscle_electrophysio | 0.64697136 |
| 152 | MP0003942_abnormal_urinary_system | 0.64319412 |
| 153 | MP0000703_abnormal_thymus_morphology | 0.63658236 |
| 154 | MP0001348_abnormal_lacrimal_gland | 0.63325425 |
| 155 | MP0003283_abnormal_digestive_organ | 0.62791840 |
| 156 | MP0000858_altered_metastatic_potential | 0.62069983 |
| 157 | MP0001697_abnormal_embryo_size | 0.62020987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mesangial abnormality (HP:0001966) | 5.72879396 |
| 2 | Focal segmental glomerulosclerosis (HP:0000097) | 3.64740420 |
| 3 | Lymphangioma (HP:0100764) | 3.60951250 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.52023373 |
| 5 | Obstructive sleep apnea (HP:0002870) | 3.45449648 |
| 6 | Sudden death (HP:0001699) | 3.24308721 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.14617975 |
| 8 | Hyperacusis (HP:0010780) | 3.12059553 |
| 9 | Rapidly progressive (HP:0003678) | 3.05179827 |
| 10 | Vertebral compression fractures (HP:0002953) | 2.98244183 |
| 11 | Abnormal albumin level (HP:0012116) | 2.94928468 |
| 12 | Hypoalbuminemia (HP:0003073) | 2.94928468 |
| 13 | Ankle contracture (HP:0006466) | 2.91927001 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 2.89844445 |
| 15 | Polycythemia (HP:0001901) | 2.82217572 |
| 16 | Hypoproteinemia (HP:0003075) | 2.74282073 |
| 17 | Distal lower limb amyotrophy (HP:0008944) | 2.74044806 |
| 18 | Glomerulosclerosis (HP:0000096) | 2.72188261 |
| 19 | Ventricular tachycardia (HP:0004756) | 2.71326448 |
| 20 | Muscle fiber splitting (HP:0003555) | 2.70553465 |
| 21 | Difficulty climbing stairs (HP:0003551) | 2.70515290 |
| 22 | Supraventricular arrhythmia (HP:0005115) | 2.66878714 |
| 23 | Bundle branch block (HP:0011710) | 2.65291188 |
| 24 | Primary atrial arrhythmia (HP:0001692) | 2.64965032 |
| 25 | Papilledema (HP:0001085) | 2.63813831 |
| 26 | Supraventricular tachycardia (HP:0004755) | 2.61824936 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61051777 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61051777 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61051777 |
| 30 | Atrial fibrillation (HP:0005110) | 2.57576386 |
| 31 | Atrioventricular block (HP:0001678) | 2.56689213 |
| 32 | Broad face (HP:0000283) | 2.56305548 |
| 33 | Subaortic stenosis (HP:0001682) | 2.55353037 |
| 34 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.55353037 |
| 35 | Dysmetric saccades (HP:0000641) | 2.55094057 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.51960947 |
| 37 | Aortic aneurysm (HP:0004942) | 2.50702154 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.50054254 |
| 39 | Limb-girdle muscle atrophy (HP:0003797) | 2.48895757 |
| 40 | Vascular tortuosity (HP:0004948) | 2.48698443 |
| 41 | Broad metatarsal (HP:0001783) | 2.46978358 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 2.45620404 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.45236268 |
| 44 | Axonal loss (HP:0003447) | 2.41597079 |
| 45 | Aneurysm (HP:0002617) | 2.41403222 |
| 46 | Enlarged penis (HP:0000040) | 2.39992327 |
| 47 | Arterial tortuosity (HP:0005116) | 2.37722469 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.35150084 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.33441819 |
| 50 | Fragile skin (HP:0001030) | 2.32452091 |
| 51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.32226239 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 2.30841493 |
| 53 | Upper limb amyotrophy (HP:0009129) | 2.30841493 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29752528 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29752528 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29752528 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27509590 |
| 58 | Aortic dissection (HP:0002647) | 2.27121093 |
| 59 | Abnormality of the fingertips (HP:0001211) | 2.26326851 |
| 60 | Abnormal platelet function (HP:0011869) | 2.25104408 |
| 61 | Impaired platelet aggregation (HP:0003540) | 2.25104408 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.24978152 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24978152 |
| 64 | Acute lymphatic leukemia (HP:0006721) | 2.24861160 |
| 65 | Shallow orbits (HP:0000586) | 2.23525951 |
| 66 | Atrophic scars (HP:0001075) | 2.22990263 |
| 67 | Disproportionate tall stature (HP:0001519) | 2.21360976 |
| 68 | Achilles tendon contracture (HP:0001771) | 2.20462532 |
| 69 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.18680729 |
| 70 | Peritonitis (HP:0002586) | 2.18127684 |
| 71 | Lipoatrophy (HP:0100578) | 2.17910050 |
| 72 | Nuclear cataract (HP:0100018) | 2.17501616 |
| 73 | Myotonia (HP:0002486) | 2.17326280 |
| 74 | Mitral regurgitation (HP:0001653) | 2.16340138 |
| 75 | Wormian bones (HP:0002645) | 2.15549024 |
| 76 | Abnormal number of erythroid precursors (HP:0012131) | 2.15237847 |
| 77 | Increased connective tissue (HP:0009025) | 2.13445015 |
| 78 | Pointed chin (HP:0000307) | 2.11364295 |
| 79 | Type 1 muscle fiber predominance (HP:0003803) | 2.10908763 |
| 80 | Difficulty running (HP:0009046) | 2.08914276 |
| 81 | Heart block (HP:0012722) | 2.08830332 |
| 82 | Blue sclerae (HP:0000592) | 2.08537306 |
| 83 | Hyporeflexia of lower limbs (HP:0002600) | 2.08518713 |
| 84 | Joint stiffness (HP:0001387) | 2.06040751 |
| 85 | Thin bony cortex (HP:0002753) | 2.04807507 |
| 86 | Renal duplication (HP:0000075) | 2.02598792 |
| 87 | Bladder diverticulum (HP:0000015) | 2.02560589 |
| 88 | Abnormality of the nasal mucosa (HP:0000433) | 2.01796614 |
| 89 | Visual hallucinations (HP:0002367) | 1.99848410 |
| 90 | Abnormal atrioventricular conduction (HP:0005150) | 1.96710681 |
| 91 | Emphysema (HP:0002097) | 1.94824139 |
| 92 | EMG: myopathic abnormalities (HP:0003458) | 1.94350506 |
| 93 | Bowel diverticulosis (HP:0005222) | 1.94245601 |
| 94 | Eczematoid dermatitis (HP:0000976) | 1.94076419 |
| 95 | Slender build (HP:0001533) | 1.93247736 |
| 96 | Petechiae (HP:0000967) | 1.92251413 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 1.91879243 |
| 98 | Long eyelashes (HP:0000527) | 1.91516704 |
| 99 | Abnormality of the calf musculature (HP:0001430) | 1.91443970 |
| 100 | Spinal canal stenosis (HP:0003416) | 1.90278682 |
| 101 | Abnormality of the Achilles tendon (HP:0005109) | 1.89080277 |
| 102 | Ulnar bowing (HP:0003031) | 1.88238452 |
| 103 | Dilated cardiomyopathy (HP:0001644) | 1.88173078 |
| 104 | Mitral valve prolapse (HP:0001634) | 1.88136838 |
| 105 | Macroorchidism (HP:0000053) | 1.87701648 |
| 106 | Elfin facies (HP:0004428) | 1.86380478 |
| 107 | Insomnia (HP:0100785) | 1.85958798 |
| 108 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.85486220 |
| 109 | Short nail (HP:0001799) | 1.84661330 |
| 110 | Broad palm (HP:0001169) | 1.84095536 |
| 111 | Exostoses (HP:0100777) | 1.83222163 |
| 112 | Apathy (HP:0000741) | 1.82631726 |
| 113 | Spontaneous hematomas (HP:0007420) | 1.82365211 |
| 114 | Abnormality of macrophages (HP:0004311) | 1.81858529 |
| 115 | Systemic lupus erythematosus (HP:0002725) | 1.81093233 |
| 116 | Exercise-induced muscle cramps (HP:0003710) | 1.80539196 |
| 117 | Visceral angiomatosis (HP:0100761) | 1.79548867 |
| 118 | Long palpebral fissure (HP:0000637) | 1.78163855 |
| 119 | Joint laxity (HP:0001388) | 1.76956234 |
| 120 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76612581 |
| 121 | Hematochezia (HP:0002573) | 1.76155666 |
| 122 | Hand muscle atrophy (HP:0009130) | 1.75226499 |
| 123 | Diminished motivation (HP:0000745) | 1.74884292 |
| 124 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74863124 |
| 125 | Increased cerebral lipofuscin (HP:0011813) | 1.74262517 |
| 126 | Wrist flexion contracture (HP:0001239) | 1.74014309 |
| 127 | Lymphedema (HP:0001004) | 1.73933232 |
| 128 | Annular pancreas (HP:0001734) | 1.73893418 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.73766720 |
| 130 | Spondylolisthesis (HP:0003302) | 1.73733792 |
| 131 | Hypoventilation (HP:0002791) | 1.73613021 |
| 132 | Hemangiomatosis (HP:0007461) | 1.72906872 |
| 133 | Progressive muscle weakness (HP:0003323) | 1.72741323 |
| 134 | J-shaped sella turcica (HP:0002680) | 1.72357401 |
| 135 | Foot dorsiflexor weakness (HP:0009027) | 1.70557784 |
| 136 | EMG: neuropathic changes (HP:0003445) | 1.70161053 |
| 137 | Premature rupture of membranes (HP:0001788) | 1.69545345 |
| 138 | Hyperextensible skin (HP:0000974) | 1.69047937 |
| 139 | Genu recurvatum (HP:0002816) | 1.68193387 |
| 140 | Neoplasm of the heart (HP:0100544) | 1.67701228 |
| 141 | Calf muscle hypertrophy (HP:0008981) | 1.67258401 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.66410929 |
| 143 | Amyloidosis (HP:0011034) | 1.66350935 |
| 144 | Spinal rigidity (HP:0003306) | 1.65690549 |
| 145 | Lumbar hyperlordosis (HP:0002938) | 1.65689307 |
| 146 | Dilatation of the ascending aorta (HP:0005111) | 1.65110454 |
| 147 | Abnormality of the lower motor neuron (HP:0002366) | 1.64935330 |
| 148 | Hemiplegia (HP:0002301) | 1.64702307 |
| 149 | Exercise-induced myalgia (HP:0003738) | 1.64640849 |
| 150 | Biconcave vertebral bodies (HP:0004586) | 1.64296549 |
| 151 | Cellulitis (HP:0100658) | 1.64084223 |
| 152 | Abnormality of binocular vision (HP:0011514) | 1.63910062 |
| 153 | Diplopia (HP:0000651) | 1.63910062 |
| 154 | Ventricular fibrillation (HP:0001663) | 1.63811467 |
| 155 | Genetic anticipation (HP:0003743) | 1.63518344 |
| 156 | Hypercortisolism (HP:0001578) | 1.63130859 |
| 157 | Ulnar deviation of the wrist (HP:0003049) | 1.63050347 |
| 158 | Mitral stenosis (HP:0001718) | 1.62806424 |
| 159 | Ankle clonus (HP:0011448) | 1.62531240 |
| 160 | Bicuspid aortic valve (HP:0001647) | 1.62329845 |
| 161 | Easy fatigability (HP:0003388) | 1.61795241 |
| 162 | Chronic otitis media (HP:0000389) | 1.61717222 |
| 163 | Lower limb amyotrophy (HP:0007210) | 1.61615352 |
| 164 | Cervical subluxation (HP:0003308) | 1.61212173 |
| 165 | Fatigue (HP:0012378) | 1.60929309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.03762940 |
| 2 | EEF2K | 3.72652726 |
| 3 | TIE1 | 3.65523134 |
| 4 | PRPF4B | 3.15497347 |
| 5 | PKN2 | 3.02130253 |
| 6 | KDR | 2.84407491 |
| 7 | IRAK3 | 2.22028083 |
| 8 | TTN | 2.21329650 |
| 9 | ICK | 2.09261663 |
| 10 | PAK4 | 2.05103133 |
| 11 | ERN1 | 1.95837883 |
| 12 | MYLK | 1.94189712 |
| 13 | TGFBR2 | 1.89011382 |
| 14 | PRKD3 | 1.82799345 |
| 15 | MAP3K10 | 1.77581035 |
| 16 | EPHB1 | 1.74784184 |
| 17 | SCYL2 | 1.72502984 |
| 18 | EPHB2 | 1.71238536 |
| 19 | TGFBR1 | 1.66614345 |
| 20 | SMG1 | 1.60568698 |
| 21 | TAOK1 | 1.56993009 |
| 22 | SIK3 | 1.56082662 |
| 23 | DMPK | 1.55982617 |
| 24 | MAPKAPK3 | 1.54662969 |
| 25 | RIPK4 | 1.53267590 |
| 26 | CDK19 | 1.52991979 |
| 27 | RIPK1 | 1.49810538 |
| 28 | TESK1 | 1.48570282 |
| 29 | NEK1 | 1.47734582 |
| 30 | ARAF | 1.46289316 |
| 31 | TAOK2 | 1.46152797 |
| 32 | MAP3K3 | 1.41756315 |
| 33 | MAP3K13 | 1.40806927 |
| 34 | MAP3K7 | 1.38669486 |
| 35 | LRRK2 | 1.37010140 |
| 36 | ILK | 1.30176422 |
| 37 | DDR2 | 1.28354540 |
| 38 | SIK2 | 1.27004696 |
| 39 | FES | 1.26621434 |
| 40 | KIT | 1.22550584 |
| 41 | PTK2B | 1.21234661 |
| 42 | CAMKK1 | 1.20781705 |
| 43 | DAPK1 | 1.18801511 |
| 44 | PTK2 | 1.16642853 |
| 45 | PDGFRA | 1.16489203 |
| 46 | NTRK3 | 1.15265965 |
| 47 | CAMK1 | 1.14113015 |
| 48 | RPS6KB2 | 1.13338869 |
| 49 | MAP2K3 | 1.11610183 |
| 50 | MARK2 | 1.10879052 |
| 51 | PAK2 | 1.08368944 |
| 52 | PIM2 | 1.05680028 |
| 53 | IRAK4 | 1.04621306 |
| 54 | IRAK2 | 1.04527963 |
| 55 | BLK | 1.04037517 |
| 56 | MOS | 1.01279369 |
| 57 | MINK1 | 1.01137475 |
| 58 | ALK | 1.00134501 |
| 59 | TBK1 | 0.99303984 |
| 60 | MAP3K6 | 0.99240849 |
| 61 | PDPK1 | 0.95656405 |
| 62 | WNK4 | 0.95107266 |
| 63 | TYK2 | 0.94904703 |
| 64 | CAMK1G | 0.94899278 |
| 65 | RET | 0.92060743 |
| 66 | MAP3K4 | 0.88415824 |
| 67 | PRKD2 | 0.88374537 |
| 68 | NTRK1 | 0.87265643 |
| 69 | CAMK1D | 0.87089824 |
| 70 | NME2 | 0.83578199 |
| 71 | CAMKK2 | 0.83504444 |
| 72 | MAP4K1 | 0.82343228 |
| 73 | MATK | 0.80918755 |
| 74 | PTK6 | 0.80623639 |
| 75 | MAP3K12 | 0.79824950 |
| 76 | KSR2 | 0.78043332 |
| 77 | CSK | 0.77887484 |
| 78 | MARK1 | 0.76620715 |
| 79 | FGFR4 | 0.76353280 |
| 80 | RPS6KA2 | 0.76135228 |
| 81 | MAPK12 | 0.73409112 |
| 82 | CAMK4 | 0.71487859 |
| 83 | KSR1 | 0.70830227 |
| 84 | PRKCH | 0.70579583 |
| 85 | MTOR | 0.70429001 |
| 86 | SGK3 | 0.67390940 |
| 87 | HIPK2 | 0.67189948 |
| 88 | TNK2 | 0.66851370 |
| 89 | MAPK7 | 0.66351235 |
| 90 | DYRK1B | 0.65827642 |
| 91 | TESK2 | 0.65189667 |
| 92 | RAF1 | 0.63818549 |
| 93 | CDK18 | 0.62836426 |
| 94 | BTK | 0.62528337 |
| 95 | BRSK1 | 0.62331909 |
| 96 | CDK4 | 0.61157529 |
| 97 | CDK11A | 0.60823689 |
| 98 | LIMK1 | 0.60672119 |
| 99 | PRKD1 | 0.60627382 |
| 100 | EPHA2 | 0.60035108 |
| 101 | CDK15 | 0.59925644 |
| 102 | BRAF | 0.59901036 |
| 103 | MAP2K4 | 0.59702882 |
| 104 | MAP3K14 | 0.59383014 |
| 105 | PDK1 | 0.59009163 |
| 106 | TYRO3 | 0.58928120 |
| 107 | RPS6KL1 | 0.58191895 |
| 108 | MAP3K9 | 0.57820484 |
| 109 | CDK12 | 0.56203797 |
| 110 | PRKG2 | 0.55793486 |
| 111 | CDC42BPA | 0.54416413 |
| 112 | MAP3K11 | 0.54203214 |
| 113 | ZAP70 | 0.54113336 |
| 114 | PDGFRB | 0.53399601 |
| 115 | MAPK4 | 0.52924845 |
| 116 | LMTK2 | 0.52681065 |
| 117 | NEK2 | 0.52122095 |
| 118 | CDK14 | 0.51970233 |
| 119 | MARK3 | 0.51916845 |
| 120 | PAK6 | 0.50567998 |
| 121 | RPS6KA4 | 0.49447632 |
| 122 | EIF2AK1 | 0.48119369 |
| 123 | PAK3 | 0.47156447 |
| 124 | PHKG1 | 0.46783193 |
| 125 | PHKG2 | 0.46783193 |
| 126 | SIK1 | 0.46469905 |
| 127 | JAK3 | 0.46363832 |
| 128 | ABL2 | 0.45915971 |
| 129 | CDK5 | 0.45686468 |
| 130 | LATS2 | 0.44987744 |
| 131 | ROCK1 | 0.44521318 |
| 132 | BMX | 0.44249577 |
| 133 | UHMK1 | 0.42754354 |
| 134 | DAPK3 | 0.41538250 |
| 135 | MAPK9 | 0.41421291 |
| 136 | DAPK2 | 0.40284170 |
| 137 | AKT2 | 0.36719053 |
| 138 | CDK6 | 0.36661986 |
| 139 | STK38 | 0.36321614 |
| 140 | STK11 | 0.35216472 |
| 141 | MAP3K1 | 0.34831396 |
| 142 | RPS6KC1 | 0.34556185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.14021969 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06635167 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.99799369 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.99470484 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.96984733 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.87863582 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75696817 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 1.66049732 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62557297 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.58177105 |
| 11 | Glioma_Homo sapiens_hsa05214 | 1.56556178 |
| 12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56409055 |
| 13 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.50465790 |
| 14 | Platelet activation_Homo sapiens_hsa04611 | 1.50214067 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47667137 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.45665372 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.43831762 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42184337 |
| 19 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.34534440 |
| 20 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.33927707 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.32177848 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31890159 |
| 23 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31529544 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.31351192 |
| 25 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.30953321 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.27128956 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.24478303 |
| 28 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.23455652 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22887267 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21828606 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21580765 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20732112 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.19825674 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18972552 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17682111 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.17376476 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14094347 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13631261 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13298276 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08993884 |
| 41 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.08861009 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.08848410 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08606867 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07770656 |
| 45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.07215638 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.07097993 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06116516 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.05428884 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05240151 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04555476 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04234370 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 1.03476199 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03405394 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 1.02783847 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.99236011 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99203846 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99072930 |
| 58 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.99022760 |
| 59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.97878321 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97842473 |
| 61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97406572 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.97406167 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.96640885 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96411565 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96286462 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92931868 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92770519 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.92733109 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.92587381 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92393008 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91913674 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.91379787 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88772191 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.88181508 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88014618 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87977237 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87704427 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.87530850 |
| 79 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87486403 |
| 80 | DNA replication_Homo sapiens_hsa03030 | 0.85985393 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85679293 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85674701 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.85316233 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84743732 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83501257 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.83399810 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82972642 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82769390 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.82307013 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81810770 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81757529 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81568271 |
| 93 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.81350942 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81248916 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77929359 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77799663 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77436893 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77045597 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76453131 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75634395 |
| 101 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.74140921 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.73762097 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73661222 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72423757 |
| 105 | Axon guidance_Homo sapiens_hsa04360 | 0.72088021 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71976424 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71344009 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71140083 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.70969452 |
| 110 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70937956 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70843397 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70736911 |
| 113 | Influenza A_Homo sapiens_hsa05164 | 0.69750494 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.68978607 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68315185 |
| 116 | Cell cycle_Homo sapiens_hsa04110 | 0.68019635 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67215645 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.66786288 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66500026 |
| 120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66198131 |
| 121 | Adherens junction_Homo sapiens_hsa04520 | 0.65434288 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64774641 |
| 123 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64590120 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64426459 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.64221772 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64156510 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64101576 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.63115126 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62373048 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61735409 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59335039 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58562826 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57769568 |
| 134 | GABAergic synapse_Homo sapiens_hsa04727 | 0.57660791 |

